Neuro-Oncology Reviews

Volume 28 Number 20
20 July 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 20, 20 July

van de Langerijt KA, Kibria MG, Villa GR, Mineo M.
The Hallmarks of Glioblastoma: Functional Interplay Between Long Non-Coding RNAs and RNA-Binding Proteins.
Cells. 2026 Jul 11;15(14):1251. doi: 10.3390/cells15141251. PMID: 42505361. ˍ

Haddad AF, Ramesh R, Agudelo JAP, Salha C, Prakash P, Aghi SR, Trippett JS, Castro MG, Aghi MK.
Recent Advances and Future Prospects in Gene Delivery Platforms for Glioblastoma: A Review.
JAMA Neurol. 2026 Jul 13. doi: 10.1001/jamaneurol.2026.2131. PMID: 42440296˰ ˍ

Crombet Ramos T, Díaz Miqueli A, Pérez Rodríguez R.
Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.
Biomedicines. 2026 Jul 14;14(7):1570. doi: 10.3390/biomedicines14071570. PMID: 42512043. ˍ

Omene E.
Metabolic cell competition in the glioblastoma tumour microenvironment: glucose, glutamine, and lactate as determinants of immune exclusion and targets for pharmacological reprogramming.
Front Oncol. 2026 Jul 14;16:1849888. doi: 10.3389/fonc.2026.1849888. PMID: 42523684. ˍ

Saxena A, Bayik D.
Metabolism of myeloid cells in brain tumors.
Front Immunol. 2026 Jul 14;17:1894833. doi: 10.3389/fimmu.2026.1894833. PMID: 42523669. ˍ

Srinivasan S, Eraghi MM, Odiase P, Mazumder S, Ahuja A, Ranganathan S, Patel P, O'Leary S, Guirguis M, Barrie U, Sun MZ, Patel A.
Prognostic utility of tumor grade and IDH-mutation status for immunotherapy response in high grade glioma: a systematic review and meta-analysis.
J Clin Neurosci. 2026 Jul 20;152:112202. doi: 10.1016/j.jocn.2026.112202. PMID: 42475978. ˍ